NDC11 10135072205
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 10135-0722-05 | 10135-0722 |
| 10135-0722-5 | 10135-0722 |
| 10135-722-05 | 10135-722 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2025-11-21 | Warnings, Adverse reactions | 10135-722-05 10135-722 10135072205 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.